Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Farmers Insurance
US Army
Covington
Baxter
Citi
Colorcon
Medtronic
Moodys
AstraZeneca

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,674,799

« Back to Dashboard

Summary for Patent: 7,674,799
Title:Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
Abstract:In certain embodiments the invention is directed to a process for preparing an oxycodone hydrochloride composition having less than 25 ppm of 14-hydroxycodeinone.
Inventor(s): Chapman; Robert (North Kingstown, RI), Rider; Lonn S. (Foster, RI), Hong; Qi (Sharon, MA), Kyle; Donald (Newtown, PA), Kupper; Robert (Coventry, RI)
Assignee: Purdue Pharma L.P. (Stamford, CT)
Application Number:11/653,531
Patent Claim Types:
see list of patent claims
Formulation; Compound; Dosage form; Composition;

Drugs Protected by US Patent 7,674,799

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Purdue Pharma Lp OXYCONTIN oxycodone hydrochloride TABLET, EXTENDED RELEASE;ORAL 022272-001 Apr 5, 2010 RX Yes No ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Purdue Pharma Lp OXYCONTIN oxycodone hydrochloride TABLET, EXTENDED RELEASE;ORAL 022272-002 Apr 5, 2010 RX Yes No ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Purdue Pharma Lp OXYCONTIN oxycodone hydrochloride TABLET, EXTENDED RELEASE;ORAL 022272-003 Apr 5, 2010 RX Yes No ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Purdue Pharma Lp OXYCONTIN oxycodone hydrochloride TABLET, EXTENDED RELEASE;ORAL 022272-005 Apr 5, 2010 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 7,674,799

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,129,248 Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone ➤ Subscribe
9,522,919 Oxycodone compositions ➤ Subscribe
8,822,687 8a,14-dihydroxy-7,8-dihydrocodeinone ➤ Subscribe
9,073,933 Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone ➤ Subscribe
7,674,798 Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone ➤ Subscribe
7,674,800 Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone ➤ Subscribe
7,683,072 Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone ➤ Subscribe
9,777,011 Process for preparing oxycodone compositions ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,674,799

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 2232 ➤ Subscribe
Argentina 049012 ➤ Subscribe
Austria 501150 ➤ Subscribe
Austria 9952 ➤ Subscribe
Australia 2005230826 ➤ Subscribe
Australia 2009200335 ➤ Subscribe
Australia 2011213801 ➤ Subscribe
Australia 2013202453 ➤ Subscribe
Australia 2015261590 ➤ Subscribe
Australia 2017204741 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Argus Health
Federal Trade Commission
Novartis
Accenture
Healthtrust
McKinsey
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot